FH and atherosclerosis: Statins have increasingly been used in children and adolescents, including those at risk for premature ASCVD (e.g., FH): as in adults, statins effectively improve the lipid profile (mainly by lowering LDL-C), slow the progression of the atherosclerotic process and reduce atherosclerotic burden in adulthood.